Novartis Ag (NVS) Gross Profit (2009 - 2025)
Novartis Ag recorded quarterly Gross Profit of $11.5 billion in Q2 2025, down 38.5% quarter-over-quarter from $18.7 billion in Q4 2024, and up 18.71% year-over-year from $9.7 billion in Q2 2024.
Novartis Ag's Gross Profit history runs 16 years deep, the most recent figure standing at $11.5 billion for Q2 2025.
- In Q2 2025, Gross Profit rose 18.71% year-over-year to $11.5 billion; the TTM figure through Jun 2025 stood at $56.4 billion (down 98.88% YoY), while the FY2025 annual figure was $43.0 billion, up 10.49% from the prior year.
- Gross Profit came in at $11.5 billion for Q2 2025 at Novartis Ag, down from $18.7 billion in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $5000.0 billion in Q1 2023 to a low of -$34.0 million in Q2 2022.
- A 5-year average of $363.8 billion and a median of $4.9 billion in 2022 frame the typical range for Gross Profit.
- Across the five-year window, Gross Profit slumped 143.04% in 2022 and jumped 14705782.35% in 2023, its largest moves.
- Novartis Ag's Gross Profit stood at $14.0 million in 2021, then soared by 130557.14% to $18.3 billion in 2022, then retreated by 10.02% to $16.5 billion in 2023, then rose by 13.76% to $18.7 billion in 2024, then slumped by 38.5% to $11.5 billion in 2025.
- According to Business Quant data, Gross Profit over the past three periods registered $11.5 billion, $18.7 billion, and $9.7 billion for Q2 2025, Q4 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 11.51 Bn |
| Jun 30, 2025 | 11.51 Bn |
| Dec 31, 2024 | 18.72 Bn |
| Dec 31, 2024 | 18.72 Bn |
| Jun 30, 2024 | 9.70 Bn |
| Jun 30, 2024 | 9.70 Bn |
| Dec 31, 2023 | 16.46 Bn |
| Dec 31, 2023 | 16.46 Bn |
| Jun 30, 2023 | 18.87 Bn |
| Jun 30, 2023 | 18.87 Bn |
| Mar 31, 2023 | 5,000.00 Bn |
| Mar 31, 2023 | 5,000.00 Bn |
| Dec 31, 2022 | 18.29 Bn |
| Dec 31, 2022 | 18.29 Bn |
| Sep 30, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | -33.98 Mn |
| Jun 30, 2022 | -33.98 Mn |
| Mar 31, 2022 | 34.00 Mn |
| Mar 31, 2022 | 34.00 Mn |
| Dec 31, 2021 | 14.00 Mn |
| Dec 31, 2021 | 14.00 Mn |
| Sep 30, 2021 | 21.00 Mn |
| Sep 30, 2021 | 21.00 Mn |
| Jun 30, 2021 | -13.98 Mn |
| Jun 30, 2021 | -13.98 Mn |
| Mar 31, 2021 | 14.00 Mn |
| Mar 31, 2021 | 14.00 Mn |
| Dec 31, 2020 | 17.18 Bn |
| Dec 31, 2020 | 17.18 Bn |
| Sep 30, 2020 | 18.00 Mn |
| Sep 30, 2020 | 18.00 Mn |
| Jun 30, 2020 | 17.00 Bn |
| Jun 30, 2020 | 17.00 Bn |
| Mar 31, 2020 | 177.00 Mn |
| Mar 31, 2020 | 177.00 Mn |
| Mar 31, 2019 | 21.00 Mn |
| Mar 31, 2019 | 21.00 Mn |
| Dec 31, 2018 | 879.00 Mn |
| Dec 31, 2018 | 879.00 Mn |
| Sep 30, 2018 | 549.00 Mn |
| Sep 30, 2018 | 549.00 Mn |
| Jun 30, 2018 | 8.98 Bn |
| Jun 30, 2018 | 8.98 Bn |
| Mar 31, 2018 | 16.00 Mn |
| Mar 31, 2018 | 16.00 Mn |
| Dec 31, 2017 | 820.00 Mn |
| Dec 31, 2017 | 820.00 Mn |
| Sep 30, 2017 | 831.00 Mn |
| Sep 30, 2017 | 831.00 Mn |
| Jun 30, 2017 | 8.24 Bn |
| Jun 30, 2017 | 8.24 Bn |
| Mar 31, 2017 | 724.00 Mn |
| Mar 31, 2017 | 724.00 Mn |
| Dec 31, 2016 | 30.52 Bn |
| Dec 31, 2016 | 30.52 Bn |
| Sep 30, 2016 | 672.00 Mn |
| Sep 30, 2016 | 672.00 Mn |
| Jun 30, 2016 | 723.00 Mn |
| Jun 30, 2016 | 723.00 Mn |
| Mar 31, 2016 | 667.00 |
| Mar 31, 2016 | 667.00 |
| Dec 31, 2015 | 973.00 Mn |
| Dec 31, 2015 | 973.00 Mn |
| Sep 30, 2015 | 0.00 |
| Sep 30, 2015 | 0.00 |
| Mar 31, 2015 | 752.00 |
| Mar 31, 2015 | 752.00 |
| Dec 31, 2014 | 93.00 |
| Dec 31, 2014 | 93.00 |
| Sep 30, 2014 | 114.00 |
| Sep 30, 2014 | 114.00 |
| Mar 31, 2014 | 615.00 |
| Mar 31, 2014 | 615.00 |
| Sep 30, 2012 | 871.00 |
| Sep 30, 2012 | 871.00 |
| Jun 30, 2012 | 958.00 |
| Jun 30, 2012 | 958.00 |
| Mar 31, 2012 | 958.00 |
| Mar 31, 2012 | 958.00 |
| Dec 31, 2011 | 623.00 |
| Dec 31, 2011 | 623.00 |
| Sep 30, 2011 | 767.00 |
| Sep 30, 2011 | 767.00 |
| Jun 30, 2011 | 783.00 |
| Jun 30, 2011 | 783.00 |
| Mar 31, 2011 | 762.00 |
| Mar 31, 2011 | 762.00 |
| Dec 31, 2010 | 749.00 |
| Dec 31, 2010 | 749.00 |
| Sep 30, 2010 | 738.00 |
| Sep 30, 2010 | 738.00 |
| Jun 30, 2010 | 917.00 |
| Jun 30, 2010 | 917.00 |
| Mar 31, 2010 | 9,260.00 |
| Mar 31, 2010 | 9,260.00 |
| Dec 31, 2009 | 0.03 |
| Dec 31, 2009 | 0.03 |
| Sep 30, 2009 | 8,187.00 |
| Sep 30, 2009 | 8,187.00 |
| Jun 30, 2009 | 7,918.00 |
| Jun 30, 2009 | 7,918.00 |
| Mar 31, 2009 | 7,341.00 |
| Mar 31, 2009 | 7,341.00 |